Cantor Fitzgerald Downgrades Aetna (AET) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Aetna (AET) Tops Q3 EPS by 37c, Miss on Revenues; Offers FY17 EPS Guidance Above Consensus
October 31, 2017 6:03 AM EDTAetna (NYSE: AET) reported Q3 EPS of $2.45, $0.37 better than the analyst estimate of $2.08. Revenue for the quarter came in at $14.95 billion versus the consensus estimate of $15.12 billion.
Total Company Results
Net income(1) was $838 million for third-quarter 2017 compared with $604 million for third-quarter 2016. The increase in net income during third-quarter 2017 was primarily due to the increase in adjusted earnings described below and lower transaction and integration-related costs in 2017 compared to 2016.Adjusted earnings(2) were $814 million for third-quarter 2017 compared with $734 million for third-quarter 2016. The increase in adjusted earnings during third-quarter 2017 was primarily due to... MoreCVS Health in talks to buy health insurer Aetna: WSJ
October 26, 2017 4:09 PM EDT(Reuters) - Drug retailer CVS Health Corp (NYSE: CVS) is in talks to buy health insurer Aetna Inc (NYSE: AET), the Wall Street Journal reported on Thursday, citing sources.
Aetna's shares closed up 11.5 percent at $178.60, after hitting $184.98.
CVS... More
